PubMed Health⌕ Search

Biomedical subjects

D R Chettle

Publications and source records attributed to D R Chettle.

At least 55 records · Page 3Linked to original sources
PubMed1993

An improved instrument for the in vivo detection of lead in bone.

An improved instrument for the fluorescence excitation measurement of concentrations of lead in bone has been developed. This is based on a large area high purity germanium detector and a point source of 109Cd. The source is positioned in a tungsten shield at the centre of the detector face such that 88keV photons cannot enter the detector directly. In vivo measurements are calibrated with plaster of Paris phantoms. Occupationally non-exposed men show a minimum detectable concentration of about 6 micrograms/g bone mineral. Measurements of tibia lead concentrations in 30 non-occupationally exposed men between the ages of 23 and 73 showed an annual increment of 0.46 microgram/g bone mineral/year. The mean deviation from the regression of tibia lead upon age was 3.5 micrograms/g bone mineral. Tibia lead concentration in one subject with a history of exposure to lead was 69.6 (SD 3.5) micrograms/g bone mineral. The improved precision of the point source large detector system means that greater confidence can be placed on the results of in vivo measurements of lead concentration. This will allow studies of the natural history of non-occupational lead accumulation in normal subjects and should permit investigations of the efficacy of therapeutic interventions in subjects poisoned with lead.

Adult↗
PubMed1992

Further scientific issues in determining an occupational standard for cadmium.

This contribution responds to the recent paper of Thun et al. (American Journal of Industrial Medicine 20:629-642, 1991) on an occupational standard for cadmium. The contribution of non-invasive in situ measurements of cadmium in liver and in kidney to the study of cadmium industrial toxicology is particularly reviewed. It is contended that clear scientific grounds do not exist for recommending cadmium in air occupational standard below 10 micrograms m-3, and that other arguments would need to be adduced to support a recommendation for a lower level. Last, a number of unanswered questions are identified and the need for further work is highlighted.

Air Pollutants, Occupational↗
PubMed1992

In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies.

Independent experiments have been performed at two centers, to evaluate the dosimetric properties of their respective 109Cd K X-ray fluorescence (XRF) bone lead measurement systems. Measurements were made of the dose to several points on the skin on the lower leg, at the surface of the tibia, in the red marrow tibia cavity, at the midcalf, and in the abdominal region occupied by the conceptus. Overall agreement between the two data sets was found. Similarities and differences are discussed. The effective dose values for an in vivo measurement of tibia lead concentration in 1-, 5-, and 10-year-old and adult subjects were calculated from one data set to be 1100, 420, 190, and 34/38 (male/female) nSv, respectively, for an in vivo median precision (one standard deviation) of 4.9 micrograms Pb (g bone mineral)-1 for a 30-min adult measurement.

Adult↗
PubMed1992

A feasibility study of the in vivo measurement of aluminium in peripheral bone.

In summary, it is feasible to construct a neutron source, using the 3H(1H,n)3He reaction and the Dynamitron accelerator, which is suitable for the measurement of aluminium in vivo. It is useful to compare this system with other published data for in vivo aluminium measurement. The important parameters are presented in table 2 where MDL represents the minimum detectable level for the stated local dose. The figures in table 2 are very encouraging since the system described in this paper is at a very early stage of development. Significant improvements in sensitivity (detected 28Al counts per unit dose) should be expected from the combined effects of: (i) Increased NaI detector sizes. (ii) Neutron transport calculations to optimise the irradiation cavity. (iii) Experiments to determine the optimum source energy more precisely. (iv) Better dose delivery (giving the same dose in a shorter time). (v) More sophisticated spectroscopic data reduction. Published data on the amounts of aluminium typically found in hands of patients with renal disease (Ellis and Kelleher 1987) show that aluminium levels are likely to be in the 0.3 to about 15 mg range. Any improvements in system performance could largely be used to reduce the patient dose since the measurement sensitivity reported here is already close to that required for meaningful clinical measurements.

Aluminum↗
PubMed1992

Design studies related to an in vivo neutron activation analysis facility for measuring total body nitrogen.

Design studies relating to an in vivo prompt capture neutron activation analysis facility measuring total body nitrogen are presented. The basis of the design is a beryllium-graphite neutron collimator and reflector configuration for (alpha, n) type radionuclide neutron sources (238PuBe or 241AmBe), so as to reflect leaking, or out-scattered, neutrons towards the subject. This improves the ratio of thermal neutron flux to dose and the spatial distribution of thermal flux achieved with these sources, whilst retaining their advantage of long half-lives as compared to 252Cf based systems. The common problem of high count-rate at the detector, and therefore high nitrogen region of interest background due to pile-up, is decreased by using a set of smaller (5.1 cm diameter x 10.2 cm long) NaI(Tl) detectors instead of large ones. The facility described presents a relative error of nitrogen measurement of 3.6% and a nitrogen to background ratio of 2.3 for 0.45 mSv skin dose (assuming ten 5.1 cm x 10.2 cm NaI(Tl) detectors).

Body Composition↗
PubMed1992

Repeated measurements of tibia lead concentrations by in vivo x ray fluorescence in occupational exposure.

A group of workers occupationally exposed to lead have had measurements of their tibia lead concentrations made on two occasions separated by five years; on the second occasion calcaneus lead concentrations were also measured. The results serve to confirm the reliability of the measurement technique and to illustrate the improved precision achieved through technical improvements. More importantly, the relation between tibia lead concentration and cumulative blood lead found in this longitudinal study was entirely consistent with that previously reported, which had been based on cross sectional studies. Furthermore, the relation between lead concentrations in the tibia and in calcaneus found here was similar to that previously found in a larger cross sectional survey. It is concluded that this technique of measuring bone lead concentrations non-invasively is likely to be used increasingly as a biological monitor of cumulative exposure to lead.

Calcaneus↗
PubMed1992

Kidney effects in long term exposed lead smelter workers.

Occupational exposure to lead may cause kidney damage. This study was carried out on a cohort of 70 active and 30 retired long term exposed lead smelter workers. Their kidney function was compared with 31 active and 10 retired truck assembly workers who had no occupational exposure to lead. The lead workers had been regularly followed up with measurements of lead concentration in blood since 1950. Previous exposure to lead was calculated as a time integrated blood lead index for each worker. Blood and urine samples were obtained from all subjects. The concentration of lead in blood (B-Pb) and urine (U-Pb) was analysed. The urinary concentrations of several sensitive indicators of early tubular (U-beta 2-microglobulin (U-beta 2-m); U-N-acetyl-beta-glucosaminidase (U-NAG)) and glomerular kidney damage (U-albumin) were determined. The B-Pb and U-Pb values were significantly higher among active and retired lead workers compared with their corresponding control groups. The highest concentrations were found among the active lead workers. The concentrations of the parameters of kidney function investigated were of the same magnitude for exposed workers and controls. No clinical signs of renal impairment were found among the workers. No correlations of clinical importance existed between concentrations of U-albumin, U-beta 2-m, and U-NAG activity on the one hand and the concentrations of B-Pb, cumulative blood lead index, U-Pb, and lead concentrations in the calcaneus and tibia on the other, among lead workers and controls. Despite many years of moderate to heavy exposure to lead, particularly for the retired lead workers, no signs of adverse effects on the kidney such as early tubular or glomerular malfunction were found. Reversible changes in kidney function during the 1950s and 1960s could not be excluded, however, due to a greater exposure to lead during that time.

Adult↗
PubMed1992

Longitudinal studies of exposure to cadmium.

Measurements of urinary proteins, blood and urinary cadmium, and in vivo kidney and liver cadmium have been made for a group of workers at several times between 1981 and 1990. The possibility of the introduction of measurement artifacts due to the use of different in vivo measurement systems has been assessed and is considered to be small. Changes in cadmium body burden with time have been studied in relation to kidney function. The results suggest several interesting patterns, although more data are needed to elucidate these further. They do, however, show the effectiveness of good hygiene in the workplace.

Body Burden↗
PubMed1992

In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure.

Measurements of bone lead concentrations in the tibia, wrist, sternum, and calcaneus were performed in vivo by x ray fluorescence on active and retired lead workers from two acid battery factories, office personnel in the two factories under study, and control subjects. Altogether 171 persons were included. Lead concentrations in the tibia and ulna (representative of cortical bone) appeared to behave similarly with respect to time but the ulnar measurement was much less precise. In an analogous fashion, lead in the calcaneus and sternum (representative of trabecular bone) behaved in the same way, but sternal measurement was less precise. Groups occupationally exposed to lead were well separated from the office workers and the controls on the basis of calculated skeletal lead burdens, whereas the differences in blood lead concentrations were not as great, suggesting that the use of concentrations of lead in blood might seriously underestimate lead body burden. The exposures encountered in the study were modest, however. The mean blood lead value among active lead workers was 1.45 mumol l-1 and the mean tibial lead concentration 21.1 micrograms (g bone mineral)-1. The kinetics of lead in the tibia appeared to be noticeably different from that in the calcaneus. Tibial lead concentration increased consistently both as a function of intensity of exposure and of duration of exposure. Calcaneal lead concentration, by contrast, was strongly dependent on the intensity rather than duration of exposure. This indicated that the biological half life of lead in calcaneus was less than the seven to eight year periods into which the duration of exposure was split. Findings for retired workers clearly showed that endogenous exposure to lead arising from skeletal burdens accumulated over a working lifetime can easily produce the dominant contribution to systemic lead concentrations once occupational exposure has ceased.

Adult↗
PubMed1992

Chelated lead and bone lead.

In this study a close correlation [correlation coefficient (r) = 0.86, P less than 0.001] was found between the blood lead level of 20 lead workers and their urinary excretion of lead for 24 h after intravenous infusion with 1 g of the chelating agent calcium disodium edetate. In addition, there were significant associations between lead levels in different bones (tibia/calcaneus: r = 0.93, P less than 0.001; tibia/phalanx: r = 0.67, P less than 0.002; calcaneus/phalanx: r = 0.80, P less than 0.001), as measured by in vivo X-ray fluorescence. Chelation produced no significant change in the lead level in either tibia or calcaneus. There was a significant correlation between chelated lead and bone lead (eg, for calcaneus, r = 0.62) in currently exposed workers. However, there was no significant relationship when a retired worker and an inactive worker were included (r = 0.14). It was concluded that chelatable lead mainly reflects the blood and soft-tissue lead pool, which is only partly dependent upon the skeletal lead content that comprises the biggest share of the total body burden.

Adult↗
PubMed1991

Monte Carlo modelling of in vivo x-ray fluorescence of lead in the kidney.

A Monte Carlo program has been written to model the in vivo x-ray fluorescence of lead in the kidney, to aid the choice of one of four candidate fluorescing source/measurement geometry combinations: 109Cd/180 degrees, 57Co/90 degrees and 99Tcm at both 180 degrees and 90 degrees. Computational studies and practical considerations led to the choice of 99Tcm in a backscatter geometry for the measurement system.

Humans↗
PubMed1991

Lead in bone: sampling and quantitation using K X-rays excited by 109Cd.

Lead in bone can be measured in vivo using gamma-rays from a 109Cd source to excite lead K X-rays. Normalization of lead X-ray amplitudes to that of the elastically backscattered 88 keV gamma-rays produces a determination of the concentration of lead in bone mineral that is accurate and insensitive to variations in measurement or bone geometry. For in vivo tibia measurements, a typical precision (1 SD) of +/- 5 micrograms lead (g bone mineral)-1 is achieved for an effective dose equivalent of 2.1 microSv. Measurement can be made of any superficial bone site, but precision will vary approximately as the inverse of the square root of the mass of bone mineral sampled. The apparatus required for this technique is readily transportable, and mobile laboratory facilities are easily established.

Bone and Bones↗
PubMed1991

Neutron and cobalt-60 gamma irradiation produce similar changes in DNA supercoiling.

The effects of 60Co gamma-ray and d(20 MeV)Be neutron irradiation on DNA supercoiling have been studied using a nucleoid rewinding technique. Irradiation of viable CHO AA8 cells on ice with from 4 to 25 Gy of either radiation produced a similar resistance to rewinding of nuclear supercoils after treatment with ethidium bromide. The restitution from the effects of 12 Gy of either radiation was also similar, leaving no detectable residual damage. The discrepancy between these data and the reduced ability of neutrons to produce DNA breaks, as defined by the alkaline elution assay, is explained by the discontinuous deposition of dose associated with neutron irradiation. It is suggested from a microdosimetric analysis that the neutron radiation interacts with DNA at sites on average 5-10 times further apart than the interactions with gamma rays. The long DNA sequences which results after neutron irradiation are consequently eluted inefficiently during alkaline elution, giving a reported RBE of approximately 0.3. Restrictions in the rewinding of individual supercoils are not dependent on the interionization distance and thus give rise to an RBE of approximately 1. Furthermore, the complete removal of DNA damage, as measured by this technique, supports the hypothesis that neutron toxicity is associated with incorrect, not incomplete, rejoining of the DNA molecule.

Animals↗
PubMed1990

An improved in vivo neutron activation system for measuring kidney cadmium.

An in vivo neutron activation system for measuring kidney cadmium has been redesigned, firstly to reduce ambient dose levels and, secondly, to improve the cadmium signal to neutron dose ratio by modifying the neutron spectrum from 238Pu/Be, by interposing a beryllium premoderator. The ambient dose was reduced by a factor of seven. The overall system performance (lower limit of detection for a given dose) was improved by 40-50%. This 238Pu/Be based system now performs as well as or better than analogous 252Cf systems, without the drawback of the relatively short half life of 252Cf.

Cadmium↗
PubMed1990

Effect of occupational lead exposure on serum 1,25-dihydroxyvitamin D levels.

The effects of lead exposure on serum 1,25-dihydroxyvitamin D levels and calcium homeostasis have been studied in 63 males occupationally exposed to the metal in the UK. The exposure indices used were blood lead, reflecting short-term exposure, and an in vivo X-ray fluorescence measurement of tibia lead which reflects cumulative lead exposure. Serum 1,25-dihydroxyvitamin D levels were higher than those in a referent population, who were non-occupationally exposed to lead, and were correlated with both blood lead and tibia lead. Multiple regression analysis suggested that blood lead was the variable responsible for the increase in serum 1,25-dihydroxyvitamin D. There were no other abnormalities in calcium metabolism associated with the degree of lead exposure.

Alanine↗